We previously reported the efficiency of gene transfer in fetal monkeys usi
ng retroviral vectors and an intraperitoneal (IP) approach. Here, we explor
ed intrapulmonary administration to determine whether gene transfer can be
limited to the developing lung. The HIV-1-derived lentiviral vector (VSV-G
pseudotyped; 1 x 10(7) infectious particles/fetus), using the enhanced gree
n fluorescent protein (EGFP) as a reporter, was directly injected into feta
l lung with ultrasound guidance (n = 4; 55 or 70 days gestation; term 165 /- 10 days). Fetuses were monitored sonographically, fetal/maternal blood s
amples collected during gestation, and four of four healthy newborns were d
elivered at term. All lung lobes were positive for the transgene (less than
or equal to 1%) when assessed by PCR, and transgene expression was observe
d by direct fluorescence microscopy and flow cytometry. The results of this
study show the following: (1) successful gene transfer in fetal monkeys us
ing an intrapulmonary approach; (2) less transduction of non-pulmonary tiss
ues with gene transfer at 70 days gestation compared with 55 days gestation
or use of an IP approach; (3) that the pulmonary epithelium was EGFP-posit
ive by immunohistochemistry; and (4) no evidence of transplacental transpor
t of vector sequences or antibody responses in the dams. The results of the
se investigations indicate the efficiency of fetal gene transfer by intrapu
lmonary delivery, and emphasize the importance of the fetal monkey as a pre
clinical model system for exploring in utero genetic treatment strategies f
or pulmonary disorders.